Citigroup Inc Next Cure, Inc. Transaction History
Citigroup Inc
- $196 Billion
- Q2 2025
A detailed history of Citigroup Inc transactions in Next Cure, Inc. stock. As of the latest transaction made, Citigroup Inc holds 1,025,469 shares of NXTC stock, worth $5.99 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,025,469
Previous 1,419,370
27.75%
Holding current value
$5.99 Million
Previous $681,000
30.84%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NXTC
# of Institutions
29Shares Held
10.8MCall Options Held
0Put Options Held
0-
Sofinnova Investments, Inc. Menlo Park, CA2.67MShares$15.6 Million0.08% of portfolio
-
Affinity Asset Advisors, LLC New York, NY2.3MShares$13.4 Million0.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA872KShares$5.09 Million0.0% of portfolio
-
Black Rock Inc. New York, NY761KShares$4.45 Million0.0% of portfolio
-
Cable Car Capital LLC San Francisco, CA758KShares$4.43 Million0.11% of portfolio
About NextCure, Inc.
- Ticker NXTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,748,800
- Market Cap $162M
- Description
- NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The comp...